Anti-diabetic Drug Use and the Risk of Parkinson’s Disease among Older Adults in Japan: the LIFE Study
Objective: This study aims to assess the potential association between specific antidiabetic drug use and the risk of PD in Japan’s super-aging society. Background: Emerging…Epidemiology of Parkinson’s disease in Southern Brazil: Age- and Sex-Specific Findings from the PROBE-PD Study
Objective: To examine the prevalence of Parkinson’s disease and parkinsonism in individuals aged 60 years and older in a population-based sample from Southern Brazil, analyzing…Educational Strategies for Enhancing Caregiver Knowledge and Capacities in Parkinson’s Disease Management: A Comprehensive Review
Objective: To evaluate the effectiveness of educational strategies in enhancing caregiver knowledge, skills, and confidence in managing Parkinson’s disease (PD) and to identify gaps in…PREDIGT 2.0: A Self-Administered, Two-Step Screening Tool to Identify Individuals with Parkinson’s Disease
Objective: To pilot the 2-step PREDIGT Score model for feasibility and improve it by simplifying both steps. Background: We previously demonstrated that the original PREDIGT…Multimodal Dissection of GALC Variants Linking Olfactory Deficits to Cognitive Decline in Parkinson’s Disease
Objective: Olfactory dysfunction is highly prevalent and often precedes motor symptoms, making it a potential early biomarker for disease progression and cognitive decline in Parkinson's…Neurodegeneration Biomarkers: Correlation between Hippocampal Volume and Cognitive Performance by MoCA Test in Parkinson’s Disease
Objective: This study aims to examine the relationship between hippocampal volume, assessed through magnetic resonance imaging (MRI), and MoCA test scores in patients diagnosed with…Parkinson’s Disease and Movement Disorders Mortality in Tunisia: Insights from the National Information System on Causes-of-Death (2020-2021)
Objective: Our study aimed to describe mortality related to Parkinson's disease (PD) and movement disorders in Tunisia during 2020-2021. Background: Parkinson's disease and related movement…Elucidating Tau and Alpha-synuclein Co-pathology in RAB39b X-linked Parkinson’s Disease.
Objective: Elucidate the mechanisms underlying pathogenesis of X-linked Parkinson’s disease (PD) due to the RAB39B p.G192R mutation. Background: RAB39B p.G192R causes X-linked PD with decreased…A Long-Living Human Tissue Engineered Nigrostriatal Pathway as a Testbed to Study Parkinson’s Disease
Objective: To create a three dimensional (3D) long-living model of human tissue-engineered nigrostriatal pathway (TE-NSP) comprised of discrete somatic and axonal compartments recapitulating the native…Metabolic Imaging Correlates of Apathy in Parkinson’s Disease.
Objective: To investigate apathy-associated metabolic changes in Parkinson’s disease. Background: Apathy is a behavioral syndrome manifested as a decrease in goal-directed behaviors. It has been…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 436
- Next Page »